Exogenus Therapeutics
PrivateLast Round
Strategic
Apr 24, 2024
Total Funding Raised
$1.32M
Company Overview
Exogenus Therapeutics is a biotechnology company developing an exosome-based platform technology designed to offer a pipeline of therapeutic products for skin and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exogenus Therapeutics Comparables
Compare Exogenus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lysatpharma GmbH | 84% | |
| ConvEyXO | 83% | |
| RION | 82% |
Exogenus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Apr 24, 2024 | ||||
| Grant | Nov 9, 2022 | ||||
| Grant | Dec 30, 2019 | ||||
| Seed | Dec 10, 2015 | ||||
| Pre Seed | Aug 1, 2015 |
Exogenus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| 3xP Global | Strategic |
| COHiTEC Program | Accelerator |
| Criteria Capital Risc | Pre Seed, Seed |
| Blue Bio Value | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 1680% from 15 to 267.
- Dec 5, 2024
Grew 40% QoQ from 10 to 14 employees.
Recent news
Latest coverage and updates
- attends_eventSep 15, 2026
Exogenus Therapeutics attended event European Lifestars Awards 2026 on Sep 15th '26.
- recognized_asSep 15, 2026
Exogenus Therapeutics recognized as finalist at European Lifestars Awards 2026 on Sep 15th '26.
- recognized_asSep 15, 2026
Joana Simões Correia at Exogenus Therapeutics recognized as finalist in the Women-Led Business of the Year category at European Lifestars Awards 2026 on Sep 15th '26.
Exogenus Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Exogenus Therapeutics's valuation, stock price, and market status.
Is Exogenus Therapeutics a public or private company?
Exogenus Therapeutics is a private company.
What is the current stock price of Exogenus Therapeutics?
Exogenus Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Exogenus Therapeutics worth (valuation)?
Valuation information for Exogenus Therapeutics is not publicly available.
Can I buy Exogenus Therapeutics stock?
Exogenus Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Exogenus Therapeutics's last funding round?
Exogenus Therapeutics's most recent funding round was Strategic on April 24, 2024.
Who are the main investors in Exogenus Therapeutics?
Key investors in Exogenus Therapeutics include 3xP Global, Caixa Capital Risc.
Will Exogenus Therapeutics IPO soon?
No public IPO plans have been announced for Exogenus Therapeutics.
How can I track Exogenus Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Exogenus Therapeutics's secondary market activity and sign up for updates.